A supplement called Elcella is claimed to work in the same way as weight-loss jabs using natural oils from foods, but experts say more evidence is needed ...

Wegovy, a GLP‑1 medication similar to Ozempic, suppresses appetite and can lead to significant weight loss. Data from 2022 ...

Wegovy’s oral version of its injectable weight-loss drug is seeing tremendous interest, Novo Nordisk executive Dave Moore ...

Eli Lilly (NYSE: LLY) and Johnson & Johnson (NYSE: JNJ) both delivered strong third-quarter results, but their earnings ...

Wegovy is now available as a daily pill, but experts say strict dosing schedules and more intense side effects may not make it a better option than the injection.

Novo Nordisk (NVO) downgraded to Hold after FDA GLP-1 actions and 2026 patent cliffs threaten Wegovy supply and growth. See ...

On Friday, Novo Nordisk (NVO) shares saw an increase in pre-market trading. This market movement is directly linked to a new initiative by Amazon’s digital pharmacy. The platform announced it ...

According to an article posted by the Yale School of Medicine in July 2024, “The first drug in a class known as GLP-1 ...

With prices starting at $149 for cash-paying patients, the new Wegovy pill undercuts much of the current market.

The pill version of popular weight-loss drug Wegovy became available in the U.S. on Monday, offering patients a daily oral ...

The new oral Wegovy, launched this week, contains semaglutide, the same active ingredient as injectable Wegovy and Ozempic ...